Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liver carcinoma
|
942 | 0.637 | 0.600 | 1 | 67168129 | missense variant | G/T | snv | 0.52 | 0.51 | 0.030 | 1.000 | 3 | 2013 | 2015 | ||||
Lupus Erythematosus, Systemic
|
1172 | 0.637 | 0.600 | 1 | 67168129 | missense variant | G/T | snv | 0.52 | 0.51 | 0.030 | 1.000 | 3 | 2010 | 2016 | ||||
Malignant Neoplasms
|
1641 | 0.637 | 0.600 | 1 | 67168129 | missense variant | G/T | snv | 0.52 | 0.51 | 0.030 | 0.333 | 3 | 2013 | 2015 | ||||
Primary malignant neoplasm
|
1374 | 0.637 | 0.600 | 1 | 67168129 | missense variant | G/T | snv | 0.52 | 0.51 | 0.030 | 0.333 | 3 | 2013 | 2015 | ||||
Crohn Disease
|
1147 | 0.637 | 0.600 | 1 | 67168129 | missense variant | G/T | snv | 0.52 | 0.51 | 0.020 | 1.000 | 2 | 2008 | 2013 | ||||
Esophageal carcinoma
|
272 | 0.637 | 0.600 | 1 | 67168129 | missense variant | G/T | snv | 0.52 | 0.51 | 0.020 | 1.000 | 2 | 2012 | 2019 | ||||
Esophageal Neoplasms
|
270 | 0.637 | 0.600 | 1 | 67168129 | missense variant | G/T | snv | 0.52 | 0.51 | 0.020 | 1.000 | 2 | 2012 | 2019 | ||||
Immune thrombocytopenic purpura
|
35 | 0.637 | 0.600 | 1 | 67168129 | missense variant | G/T | snv | 0.52 | 0.51 | 0.020 | 0.500 | 2 | 2013 | 2016 | ||||
Malignant neoplasm of esophagus
|
214 | 0.637 | 0.600 | 1 | 67168129 | missense variant | G/T | snv | 0.52 | 0.51 | 0.020 | 1.000 | 2 | 2012 | 2019 | ||||
Anemia
|
94 | 0.637 | 0.600 | 1 | 67168129 | missense variant | G/T | snv | 0.52 | 0.51 | 0.010 | 1 | 2017 | 2017 | |||||
Ankylosing spondylitis
|
609 | 0.637 | 0.600 | 1 | 67168129 | missense variant | G/T | snv | 0.52 | 0.51 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
Autoimmune thrombocytopenia
|
7 | 0.637 | 0.600 | 1 | 67168129 | missense variant | G/T | snv | 0.52 | 0.51 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Behcet Syndrome
|
243 | 0.637 | 0.600 | 1 | 67168129 | missense variant | G/T | snv | 0.52 | 0.51 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Breast Carcinoma
|
2793 | 0.637 | 0.600 | 1 | 67168129 | missense variant | G/T | snv | 0.52 | 0.51 | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||
Cardiomyopathy, Familial Idiopathic
|
243 | 0.637 | 0.600 | 1 | 67168129 | missense variant | G/T | snv | 0.52 | 0.51 | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||
Diabetes Mellitus, Insulin-Dependent
|
954 | 0.637 | 0.600 | 1 | 67168129 | missense variant | G/T | snv | 0.52 | 0.51 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Gastrointestinal Neoplasms
|
3 | 0.637 | 0.600 | 1 | 67168129 | missense variant | G/T | snv | 0.52 | 0.51 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Hepatitis B, Chronic
|
84 | 0.637 | 0.600 | 1 | 67168129 | missense variant | G/T | snv | 0.52 | 0.51 | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||
Immune Reconstitution Inflammatory Syndrome
|
5 | 0.637 | 0.600 | 1 | 67168129 | missense variant | G/T | snv | 0.52 | 0.51 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
Immune reconstitution inflammatory syndrome [IRIS]
|
1 | 0.637 | 0.600 | 1 | 67168129 | missense variant | G/T | snv | 0.52 | 0.51 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
Intervertebral disc disorder
|
19 | 0.637 | 0.600 | 1 | 67168129 | missense variant | G/T | snv | 0.52 | 0.51 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Leukemia, Myelocytic, Acute
|
6892 | 0.637 | 0.600 | 1 | 67168129 | missense variant | G/T | snv | 0.52 | 0.51 | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||
Malaria, Falciparum
|
19 | 0.637 | 0.600 | 1 | 67168129 | missense variant | G/T | snv | 0.52 | 0.51 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
Malignant neoplasm of breast
|
3417 | 0.637 | 0.600 | 1 | 67168129 | missense variant | G/T | snv | 0.52 | 0.51 | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||
Malignant neoplasm of stomach
|
615 | 0.637 | 0.600 | 1 | 67168129 | missense variant | G/T | snv | 0.52 | 0.51 | 0.010 | 1.000 | 1 | 2010 | 2010 |